Skip to main content
Have a personal or library account? Click to login
Role of radiotherapy in melanoma management Cover

Role of radiotherapy in melanoma management

Radiology and Oncology
Volume 44 (2010): Issue 1 (March 2010)
By:   
Open Access
|Mar 2010
References

References

  1. de Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilization in western Europe and decreases in Scandinavia.2003;: 119-26.
    Open DOISearch in Google Scholar
  2. . Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2000.
    Search in Google Scholar
  3. . Ljubljana: Institute of Oncology Ljubljana, Cancer Registry of Republic of Slovenia; 2009.
    Search in Google Scholar
  4. Kingham TP, Karakousis G, Ariyan C. Randomized clinical trials in melanoma.2010;: 13-31.
    Open DOISearch in Google Scholar
  5. Paterson R. Classification of tumours in relation to radiosensitivity.1933;: 218-33.
    Open DOISearch in Google Scholar
  6. Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for melanoma. A review of the evidence.2004;: 1293-301.
    Open DOISearch in Google Scholar
  7. Overgaard J, Overgaard M, Hansen V, von der Maase H. Some factors of importance in the radiation treatment of malignant melanoma.1986;: 183-92.
    Open DOISearch in Google Scholar
  8. Bentzen SM, Overgaard J, Thames HD, Overgaard M, Hansen PV, von der Maase H, et al. Clinical radiobiology of malignant melanoma.1989;: 169-82.
    Open DOISearch in Google Scholar
  9. Rofstad EK, Wahl A, Tveit KM, Monge OR, Brustad T. Survival curves after X-ray and heat treatments for melanoma cells derived directly from surgical specimens of tumours in man.1985;: 33-44.
    Open DOISearch in Google Scholar
  10. Bentzen SM, Thames HD, Overgaard J. Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma?1990;: 117-26.
    Open DOISearch in Google Scholar
  11. Barranco SC, Romsdahl MM, Humphrey RM. The radiation response of human malignant melanoma cells frown1971;: 830-3.
    Search in Google Scholar
  12. McKay MJ, Kefford RF. The spectrum of in vitro radiosensitivity in four human melanoma cell lines is not accounted for by differential induction or rejoining of DNA double strand breaks.1995;: 345-52.
    Open DOISearch in Google Scholar
  13. Trott KR. The optimal radiation dose per fraction for the treatment of malignant melanoma.1991;: 905-7.
    Open DOISearch in Google Scholar
  14. Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA. The role of biologically effective dose (BED) in clinical oncology.2001;: 71-81.
    Search in Google Scholar
  15. Rofstad EK, Mathiesen B, Galappathi K. Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor.2004;: 13-8.
    Open DOISearch in Google Scholar
  16. Rofstad EK. Fractionation sensitivity (a/b ratio) of human melanoma xenografts.1994;: 133-8.
    Open DOISearch in Google Scholar
  17. Bello MT, Ang KK. Radiation therapy for malignant melanoma.2003;: 323-42.
    Open DOISearch in Google Scholar
  18. Sause WT, Cooper JS, Rush S, Ago CT, Cosmatos D, Coughlin CT, et al. Fraction size in external beam radiation therapy in the treatment of melanoma.1991;: 429-32.
    Open DOISearch in Google Scholar
  19. Dvořák E, Haas RE, Liebner EJ. Contribution of radiotherapy to the management of malignant melanoma. A ten year experience at the University of Illinois Hospital in Chicago.1993;: 387-99.
    Search in Google Scholar
  20. Fenig E, Eidelevich E, Njuguna E, Katz A, Gutman H, Sulkes A, Schechter J. Role of radiation therapy in the management of cutaneous malignant melanoma.1999;: 184-6.
    Open DOISearch in Google Scholar
  21. Chang DT, Amdur RJ, Morris CG, Mendenhall WM. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation.2006;: 1051-5.
    Open DOISearch in Google Scholar
  22. Strojan P, Jančar B, Čemažar M, Pohar Perme M, Hočevar M. Melanoma metastases to the neck: role of adjuvant irradiation.. In press.
    Search in Google Scholar
  23. Corry J, Smith JG, Bishop M, Ainslie J. Nodal radiation therapy for metastatic melanoma.1999;: 1065-9.
    Open DOISearch in Google Scholar
  24. Burmeister BH, Smithers BM, Burmeister E, Baumann K, Davis S, Krawitz, et al. A Prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma - Trans Tasman Radiation Oncology Group (TROG) study 96.06.2006;: 136-42.
    Open DOISearch in Google Scholar
  25. Overgaard J, von der Maase H, Overgaard M. A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma.1985;: 1837-9.
    Open DOISearch in Google Scholar
  26. Overgaard J, Gonzalez Gonzalez D, Hulshof MC, Arcangeli G, Dahl O, Mella O, et al. Randomized trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma.1995;: 795-8.
    Open DOISearch in Google Scholar
  27. Harwood AR. Conventional fractionation radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma.1983;: 1019-21.
    Open DOISearch in Google Scholar
  28. Schmid-Wendtner MH, Brunner B, Konz B, Kaudewitz P, Wendtner CM, Peter RU, et al. Fractionated radiotherapy of lentigo maligna and lentigo maligna melanoma in 64 patients.2000;: 477-82.
    Open DOISearch in Google Scholar
  29. Farshad A, Burg G, Panizzon R, Dummer R. A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays.2002;: 1042-6.
    Open DOISearch in Google Scholar
  30. Krengli M, Jereczek-Fossa BA, Kaanders JHAM, Masini L, Beldì D, Orecchia R. What is the role of radiotherapy in the treatment of mucosal melanoma of the head and neck?2008;: 121-8.
    Open DOISearch in Google Scholar
  31. Trotty A, Peters LJ. Role of radiotherapy in the primary management of mucosal melanoma of the head and neck.1993;: 246-50.
    Search in Google Scholar
  32. Krengli M, Masini L, Kaanders JHA, Maingon P, Oei SB, Zouhair A, et al. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study.2006;: 751-9.
    Open DOISearch in Google Scholar
  33. Leon P, Daly JM, Synnestvedt M, Schultz DJ, Elder DE, Clark WH. The prognostic implications of microscopic satellites in patients with clinical stage I melanoma.1991;: 1461-8.
    Open DOISearch in Google Scholar
  34. Kelly JW, Sagebiel RW, Calderon W, Murillo L, Dakin RL, Blois MS. The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma.1984;: 759-63.
    Open DOISearch in Google Scholar
  35. Posther KE, Selim MA, Mosca PJ, Stanley WE, Johnson JL, Tyler DS, et al. Histopathologic characteristics, recurrence patterns, and survival of 129 patients with desmoplastic melanoma.2006;: 728-39.
    Open DOISearch in Google Scholar
  36. Jaroszewski DE, Pockaj BA, DiCaudo DJ, Bite U. The clinical behavior of desmoplastic melanoma.2001;: 590-5.
    Open DOISearch in Google Scholar
  37. Vongtama R, Safa A, Gallardo D, Calcaterra T, Juillard G. Efficacy of radiation therapy in the local control of desmoplastic malignant melanoma.2003;: 423-8.
    Open DOISearch in Google Scholar
  38. Quinn MJ, Crotty KA, Thompson JF, Coates AS, O'Brien CJ, McCarthey WH. Desmoplastic and desmoplastic neutropic melanoma: experience with 280 patients.1998;: 1128-35.
    Open DOISearch in Google Scholar
  39. Arora A, Lowe L, Su L, Rees R, Bradford C, Cimmino VC, et al. Wide excision without radiation for desmoplastic melanoma.2005;: 1462-7.
    Open DOISearch in Google Scholar
  40. Johanson CR, Harwood AR, Cummings BJ, Quirt I. 0-7-21 radiotherapy in nodular melanoma.1983;: 226-32.
    Open DOISearch in Google Scholar
  41. Cooper JS, Chang WS, Oratz R, Shapiro RL, Roses DF. Elective radiation therapy for high-risk malignant melanoma.2001;: 498-502.
    Search in Google Scholar
  42. Seegenschmiedt MH, Keilholz L, Altendorf-Hofmann A, Urban A, Schell H, Hohenberger W, et al. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.1999;: 607-18.
    Open DOISearch in Google Scholar
  43. Creagan ET, Cupps RE, Ivins JC, Pritchard DJ, Sim FH, Soule EH, et al. Adjuvant radiation therapy for regional nodal metastases from malignant melanoma: a randomized, prospective study.1978;: 2206-10.
    Open DOISearch in Google Scholar
  44. Henderson MA, Burmeister B, Thompson JF, Di Iulio J, Fisher R, Hong A, et al. Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01). [Abstract].2009;: LBA9084.
    Open DOISearch in Google Scholar
  45. Calabro A, Singletary SE, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases.1989;: 1051-5.
    Open DOISearch in Google Scholar
  46. Singletary SE, Byers RM, Shallenberger R, McBride CM, Guinee VF. Prognostic factors in patients with regional cervical nodal metastases from cutaneous malignant melanoma.1986;: 371-5.
    Open DOISearch in Google Scholar
  47. O'Brien CJ, Petersen-Schaefer K, Stevens GN, Stevens GN, Bass PC, Tew P, et al. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma.1997;: 589-94.
    Open DOISearch in Google Scholar
  48. Monsour PD, Sause WT, Avent JM, Noyes RD. Local control following therapeutic nodal dissection for melanoma.1993;: 18-22.
    Open DOISearch in Google Scholar
  49. Miller EJ, Daly JM, Synnestvedt M, Schultz D, Elder D, Guerry D. Locoregional nodal relapse in melanoma.1992;: 333-40.
    Open DOISearch in Google Scholar
  50. Lee RJ, Gibbs JF, Proulx GM, Kollmorgen DR, Jia C, Kraybill WG. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.2000;: 467-74.
    Open DOISearch in Google Scholar
  51. Shen P, Wanek LA, Morton DL. Is adjuvant radiotherapy necessary after positive lymph node dissection in head and neck melanomas?2000;: 554-9.
    Open DOISearch in Google Scholar
  52. Pidhorecky I, Lee RJ, Proulx G, Kollmorgen DR, Jia C, Driscoll DL, et al. Risk factors for nodal recurrence after lymphadenectomy for melanoma.2001;: 109-15.
    Open DOISearch in Google Scholar
  53. Bowsher WG, Taylor BA, Hughes LE. Morbidity, mortality and local recurrence following regional node dissection for melanoma.1986;: 906-8.
    Open DOISearch in Google Scholar
  54. Bayers RM. The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck.1986;: 1338-41.
    Open DOISearch in Google Scholar
  55. Kretschmer L, Preusser KP. Standardized axillary lymphadenectomy improves local control but not survival in patients with palpable lymph node metastases of cutaneous malignant melanoma.2001;: 418-25.
    Open DOISearch in Google Scholar
  56. Kissin MW, Simpson DA, Easton D, White H, Westbury G. Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma.1987;: 1023-6.
    Open DOISearch in Google Scholar
  57. Hughes TMD, A'Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma.2000;: 892-901.
    Open DOISearch in Google Scholar
  58. Kretschmer L, Neumann C, Preußer KP, Marsch WC. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin.2001;: 72-8.
    Open DOISearch in Google Scholar
  59. Allan CP, Hayes AJ, Thomas JM. Ilioinguinal lymph node dissection for palpable metastatic melanoma to the groin.2008;: 982-6.
    Open DOISearch in Google Scholar
  60. Meyer T, Merkel S, Göhl J, Hohenberger W. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma.2002;: 424-30.
    Open DOISearch in Google Scholar
  61. Agrawal S, Kane JM, Guadagnolo BA, Kraybill WG, Ballo MT. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma.2009;: 5836-44.
    Open DOISearch in Google Scholar
  62. Ang KK, Peters LJ, Weber RS, Morrison WH, Frankenthaler RA, Garden AS, et al. Postoperative radiotherapy for cutaneous melanoma of the head and neck region.1994;: 795-8.
    Open DOISearch in Google Scholar
  63. Ballo MT, Bonnen MD, Garden AS, Myers JN, Gershenwald JE, Zagars GK, et al. Adjuvant irradiation for cervical lymph node metastases from melanoma.2003;: 1789-96.
    Open DOISearch in Google Scholar
  64. Ballo MT, Strom EA, Zagars GK, Bedikian AY, Prieto VG, Mansfield PF, et al. Adjuvant irradiation for axillary metastases from malignant melanoma.2002;: 964-72.
    Open DOISearch in Google Scholar
  65. Beadle BM, Guadagnolo BA, Ballo MT, Lee JE, Gershenwald JE, Cormier JN, et al. Radiation therapy field extent for adjuvant treatment of axillary metastases from malignant melanoma.2009;: 1376-82.
    Open DOISearch in Google Scholar
  66. Ballo MT, Zagars GK, Gershenwald JE, Lee JE, Mansfield PF, Kim KB, et al. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.2004;: 1079-84.
    Open DOISearch in Google Scholar
  67. Burmeister BH, Smithers BM, Poulsen M, McLeod GR, Bryant G, Tripcony L, et al. Radiation therapy for nodal disease in malignant melanoma.1995;: 369-71.
    Open DOISearch in Google Scholar
  68. Stevens G, Thompson JF, Firth I, O'Brien CJ, McCarthy WH, Quinn MJ. Locally advanced melanoma: results of postoperative hypofractionated radiation therapy.2000;: 88-94.
    Open DOISearch in Google Scholar
  69. Fuhrmann D, Lippold A, Borrosch F, Ellwanger U, Garbe C, Suter L. Should adjuvant radiotherapy be recommended following resection of regional lymph node metastases of malignant melanomas?2001;: 66-70.
    Open DOISearch in Google Scholar
  70. Ballo MT, Ross MI, Cormier JN, Myers JN, Lee JE, Gershenwald JE, et al. Combined-modality therapy for patients with regional nodal metastases from melanoma.2006;: 106-13.
    Open DOISearch in Google Scholar
  71. Moncrieff MD, Martin R, O'Brien CJ, Shannon KF, Clark JR, Gao K, et al. Adjuvant postoperative radiotherapy to the cervical lymph nodes in cutaneous melanoma: is there any benefit for high-risk patients?2008;: 3022-7.
    Open DOISearch in Google Scholar
  72. Ballo MT, Garden AS, Myers JN, Lee JE, Diaz Jr EM, Sturgis EM, et al. Melanoma metastatic to cervical lymph nodes: can radiotherapy replace formal dissection after local excision of nodal disease?2005;: 718-21.
    Open DOISearch in Google Scholar
  73. Bonnen MD, Ballo MT, Myers JN, Garden AS, Diaz JREM, Gershenwald JE, et al. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck.2004;: 383-9.
    Open DOISearch in Google Scholar
  74. Rofstad EK. Radiation sensitivityof primary tumors and metastatic lesions of malignant melanoma.1992;: 4453-7.
    Search in Google Scholar
  75. Gojkovič Horvat A, Kovač V, Strojan P. Radiotherapy in palliative treatment of painful bone metastases.2009;: 213-24.
    Search in Google Scholar
  76. Majer M, Samlowski W. Management of metastatic melanoma patients with brain metastases.2007;: 411-6.
    Open DOISearch in Google Scholar
  77. Fife KM, Colman MH, Stevens GN, Firth IC, Moon D, Shannon KF, et al. Determinants of outcome in melanoma patients with cerebral metastases.2004;: 1293-300.
    Open DOISearch in Google Scholar
  78. Gaudy-Marqueste C, Regis JM, Muracciole X, Laurans R, Richard MA, Bonerandi JJ, et al. Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy.2006;: 809-16.
    Open DOISearch in Google Scholar
  79. Rades D, Kueter JD, Pluemer A, Veninga T, Schild SE. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.2009;: 1077-81.
    Open DOISearch in Google Scholar
  80. Rajer M, Kovač V. Malignant spinal cord compression.2008;: 23-31.
    Open DOISearch in Google Scholar
  81. Klimo P, Kestle JRW, Schmidt MH. Clinical trials and evidence-based medicine for metastatic spinal disease.2004;: 549-64.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10019-010-0008-x | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 1 - 12
Published on: Mar 18, 2010
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
melanoma,
radiobiology,
radiotherapy,
fractionation,
indications,
toxicity
Related subjects:
Medicine,
Clinical medicine,
Radiology

© 2010 Primoz Strojan, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.

Volume 44 (2010): Issue 1 (March 2010)
Next article